Cancer
Malignant Esophageal Neoplasm
CI-CAN-00001127Explore in graph →
Top-level518 active trials6 approved drugs12 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001127Explore in graph →
Clinical trials
1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (169)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02527057 | Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer | unknown | — | 90 | Hunan Province Tumor HospitalOTHER | 1 | Aug 17, 2016 | clinicaltrials |
| NCT02633436 | Research on the Role of SLC1A5 in the Development of Esophageal Cancer | unknown | — | 100 | Fourth Affiliated Hospital of Guangxi Medical UniversityOTHER | 1 | Aug 12, 2016 |
| clinicaltrials |
| NCT02457650 | T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies | unknown | Phase 1 | 36 | Shenzhen Second People's HospitalOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT02604615 | The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy(DCOECRT) | unknown | Phase 3 | 60 | The First Affiliated Hospital of Henan University of Science and TechnologyOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT02644863 | Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer | unknown | Phase 2 | 60 | Shenzhen Hornetcorn Bio-technology Company, LTDINDUSTRY | 1 | May 24, 2016 | clinicaltrials |
| NCT02745561 | Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients. | unknown | Phase 2 | 22 | Hangzhou Cancer HospitalOTHER | 1 | Apr 20, 2016 | clinicaltrials |
| NCT02375581 | Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer | unknown | Phase 2 | 130 | First People's Hospital of HangzhouOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT01551641 | Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer | unknown | Phase 2 | 180 | Changzhou No.2 People's HospitalOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT02683655 | Study of Apatinib in Metastatic Esophageal Cancer | unknown | Phase 2 | 40 | Huai'an First People's HospitalOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT02677597 | Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma | unknown | Phase 3 | 268 | Fudan UniversityOTHER | 1 | Feb 9, 2016 | clinicaltrials |
| NCT02611700 | Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Carcinoma | unknown | Phase 3 | 504 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Feb 1, 2016 | clinicaltrials |
| NCT02665702 | Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas | unknown | Phase 2 | 76 | Fudan UniversityOTHER | 1 | Jan 28, 2016 | clinicaltrials |
| NCT02662348 | T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System | unknown | Phase 1 | 6 | Yi MiaoOTHER | 1 | Jan 25, 2016 | clinicaltrials |
| NCT02607540 | Different Cycles of Cisplatin-5-fluorouracil for the Chemoradiotherapy of Esophageal Squamous Cancer(PFCRTESC) | unknown | Phase 3 | 210 | The First Affiliated Hospital of Henan University of Science and TechnologyOTHER | 1 | Jan 12, 2016 | clinicaltrials |
| NCT01242124 | Impact of the Techniques for Intrathoracic Esophagogastric Anastomosis on Outcome in Ivor-Lewis Oesophagectomy | unknown | Phase 2 / Phase 3 | 40 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT02042313 | Postoperative Pain Management After Minimally Invasive Esophagectomy(MIEPVBEA) | unknown | Phase 4 | 58 | Sun Yat-sen UniversityOTHER | 1 | Dec 16, 2015 | clinicaltrials |
| NCT02628665 | Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer | unknown | Phase 3 | 40 | The First Affiliated Hospital of Henan University of Science and TechnologyOTHER | 1 | Dec 11, 2015 | clinicaltrials |
| NCT02325986 | Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer | unknown | Phase 2 | 46 | Sun Yat-sen UniversityOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT02603159 | Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent Chemoradiotherapy(DCECRT) | unknown | Phase 3 | 200 | The First Affiliated Hospital of Henan University of Science and TechnologyOTHER | 1 | Nov 11, 2015 | clinicaltrials |
| NCT02586753 | Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus | unknown | Phase 2 | 2 | Mianyang Central HospitalOTHER | 0 | Oct 26, 2015 | clinicaltrials |
| NCT02570893 | A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma | unknown | Phase 3 | 366 | Zhejiang Cancer HospitalOTHER | 1 | Oct 7, 2015 | clinicaltrials |
| NCT02461043 | Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma | unknown | Phase 3 | 386 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 1, 2015 | clinicaltrials |
| NCT02464930 | Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia | unknown | — | 220 | Midwest Biomedical ResearchOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT02448953 | Two-field Versus Three-field Lymphadenectomy in Thoracic Esophageal Carcinoma Without Cervical Lymph Node Involvement | unknown | N/A | 786 | Chinese Academy of Medical SciencesOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT02448966 | Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy | unknown | — | 1,000 | Chinese Academy of Medical SciencesOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT02448979 | Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach | unknown | Phase 3 | 800 | Chinese Academy of Medical SciencesOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT02409849 | Octreotide LAR as Maintenance Treatment for Patients With NEC | unknown | Phase 2 | 92 | Peking UniversityOTHER | 1 | Apr 7, 2015 | clinicaltrials |
| NCT02355249 | Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer | unknown | Phase 3 | 648 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT02209415 | EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer(EUFURO) | unknown | N/A | 182 | Michael Bau MortensenOTHER | 1 | Aug 5, 2014 | clinicaltrials |
| NCT02188615 | Study of Neo-adjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Squamous Cell Esophageal Cancer(NACRFMIE) | unknown | Phase 2 | 120 | Chengchu ZhuOTHER | 1 | Jul 11, 2014 | clinicaltrials |
| NCT02017002 | Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal Cancer | unknown | N/A | 100 | National Taiwan University HospitalOTHER | 1 | Jun 30, 2014 | clinicaltrials |
| NCT00004236 | Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer | unknown | Phase 2 | — | University of LeicesterOTHER | 1 | Jun 24, 2014 | clinicaltrials |
| NCT01444547 | A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin | unknown | Phase 2 | 92 | Chinese Academy of Medical SciencesOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT00425425 | Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer | unknown | Phase 1 / Phase 2 | 43 | Technical University of MunichOTHER | 1 | May 1, 2014 | clinicaltrials |
| NCT00686114 | Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancer | unknown | Phase 3 | 344 | Wenzhou Medical UniversityOTHER | 1 | Apr 29, 2014 | clinicaltrials |
| NCT01957241 | PLA for HCC and Esophageal ca Serum | unknown | — | 164 | National Taiwan University HospitalOTHER | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01927978 | Using "PET Response Criteria in Solid Tumors (PERCIST)" in Evaluating Response to Neoadjuvant Chemoradiotherpy for Esophageal Cancer | unknown | — | 60 | National Taiwan University HospitalOTHER | 1 | Apr 15, 2014 | clinicaltrials |
| NCT00903136 | Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus | unknown | Phase 1 / Phase 2 | 50 | US Department of Veterans AffairsFED | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00005607 | Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus | unknown | Phase 2 | — | Robert H. Lurie Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00010270 | LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | unknown | Phase 1 | 50 | University Hospital FreiburgOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT02016274 | Sequential Paclitaxel Plus Cisplatin Chemotherapy and Radiotherapy as 1st Line Treatment for Esophageal Squamous Cell Cancer | unknown | Phase 2 | 70 | Shen LinOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT02016287 | Sequential Paclitaxel Chemotherapy and Radiotherapy as 1st Line Treatment for Elderly Esophageal Squamous Cell Cancer | unknown | Phase 2 | 50 | Shen LinOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00005876 | Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery | unknown | Phase 2 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT01993784 | Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma. | unknown | Phase 1 / Phase 2 | 9 | Peking UniversityOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01959906 | Circumferential Section Pane Less Than 1 mm in Esophagectomy for Esophageal Cancer. | unknown | — | 923 | University Hospital, GasthuisbergOTHER | 1 | Oct 10, 2013 | clinicaltrials |
| NCT01958697 | Age and Gender Corrected Body Mass Index | unknown | — | 650 | University Hospital, GasthuisbergOTHER | 1 | Oct 9, 2013 | clinicaltrials |
| NCT00566800 | Erlotinib in Treating Patients With Barrett Esophagus | unknown | Phase 1 | 25 | Kansas City Veteran Affairs Medical CenterFED | 1 | Sep 17, 2013 | clinicaltrials |
| NCT01937208 | Comparable Study of Different Radiation Dose in Esophageal Carcinoma | unknown | Phase 3 | 300 | Zhejiang Cancer HospitalOTHER | 1 | Sep 9, 2013 | clinicaltrials |
| NCT01930630 | ESI With EUS to Differentiate T3 and T4 ESCC(ESI) | unknown | Phase 1 | 10 | Sun Yat-sen UniversityOTHER | 1 | Aug 29, 2013 | clinicaltrials |
| NCT00757614 | Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom | unknown | — | 14,000 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Aug 17, 2016source: clinicaltrials